
FDA Grants Breakthrough Device Designation to TOBY Urine-Based Test for Alzheimer’s Disease
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the TOBY Alzheimer’s Test, a urine-based diagnostic test developed by TOBY, a biotechnology company based in Austin, Texas.

